- Home
- KRMD vs SACH Comparison
KRMD vs SACH Comparison
Compare KRMD & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- SACH
- Stock Information
- Founded
- KRMD 1980
- SACH 2010
- Country
- KRMD United States
- SACH United States
- Employees
- KRMD N/A
- SACH N/A
- Industry
- KRMD Medical/Dental Instruments
- SACH Real Estate Investment Trusts
- Sector
- KRMD Health Care
- SACH Real Estate
- Exchange
- KRMD Nasdaq
- SACH Nasdaq
- Market Cap
- KRMD 127.0M
- SACH 114.0M
- IPO Year
- KRMD N/A
- SACH 2017
- Fundamental
- Price
- KRMD $2.72
- SACH $2.51
- Analyst Decision
- KRMD Strong Buy
- SACH Strong Buy
- Analyst Count
- KRMD 3
- SACH 2
- Target Price
- KRMD $3.33
- SACH $4.25
- AVG Volume (30 Days)
- KRMD 96.6K
- SACH 235.2K
- Earning Date
- KRMD 11-06-2024
- SACH 11-11-2024
- Dividend Yield
- KRMD N/A
- SACH 16.53%
- EPS Growth
- KRMD N/A
- SACH N/A
- EPS
- KRMD N/A
- SACH 0.05
- Revenue
- KRMD $30,817,017.00
- SACH $21,298,064.00
- Revenue This Year
- KRMD $15.46
- SACH N/A
- Revenue Next Year
- KRMD $17.47
- SACH N/A
- P/E Ratio
- KRMD N/A
- SACH $48.35
- Revenue Growth
- KRMD 4.70
- SACH N/A
- 52 Week Low
- KRMD $1.98
- SACH $2.22
- 52 Week High
- KRMD $3.09
- SACH $4.64
- Technical
- Relative Strength Index (RSI)
- KRMD 58.09
- SACH 51.29
- Support Level
- KRMD $2.42
- SACH $2.41
- Resistance Level
- KRMD $2.74
- SACH $2.47
- Average True Range (ATR)
- KRMD 0.14
- SACH 0.08
- MACD
- KRMD -0.01
- SACH -0.01
- Stochastic Oscillator
- KRMD 59.41
- SACH 45.45
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About SACH Sachem Capital Corp.
Sachem Capital Corp is a United States-based real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.